Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predicting the phenotype of Pompe Disease from features of GAA variants. | Eur J Hum Genet | 2025 | 39775060 | PubTator, text mining | PubMed |
| Novel rhodanine-thiazole hybrids as potential antidiabetic agents: a structure-based drug design approach. | RSC Med Chem | 2025 | 39697245 | PubTator, text mining | PubMed |
| Asymptomatic HyperCKemia in the Pediatric Population: A Prospective Study Utilizing Next-Generation Sequencing and Ancillary Tests. | Neurology | 2025 | 39666917 | PubTator, text mining | PubMed |
| A novel CD71 Centyrin:Gys1 siRNA conjugate reduces glycogen synthesis and glycogen levels in a mouse model of Pompe disease. | Mol Ther | 2025 | 39604266 | PubTator, text mining | PubMed |
| Omics analysis reveals galectin-3 to be a potential key regulator of allergic inflammation in hereditary angioedema. | J Allergy Clin Immunol Glob | 2025 | 39583036 | PubTator, text mining | PubMed |
| Actions of thyroid hormones and thyromimetics on the liver. | Nat Rev Gastroenterol Hepatol | 2025 | 39420154 | PubTator, text mining | PubMed |
| High-risk screening for late-onset Pompe disease in China: An expanded multicenter study. | J Inherit Metab Dis | 2025 | 39227307 | PubTator, text mining | PubMed |
| [Adult Pompe disease: Analysis of 13 patients]. | Med Clin (Barc) | 2025 | 39155212 | PubTator, text mining | PubMed |
| Broadening the Phenotype and Genotype Spectrum of Glycogen Storage Disease by Unraveling Novel Variants in an Iranian Patient Cohort. | Biochem Genet | 2025 | 38619706 | PubTator, text mining | PubMed |
| Biochemical and Genetic Testing of GAA in Over 30.000 Symptomatic Patients Suspected to Be Affected With Pompe Disease. | Hum Mutat | 2024 | 40225932 | PubTator, text mining | PubMed |
| Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease. | NAR Mol Med | 2024 | 39723156 | PubTator, text mining | PubMed |
| Comparative analysis of the complete chloroplast genome of Pueraria provides insights for species identification, phylogenetic relationships, and taxonomy. | BMC Plant Biol | 2024 | 39701995 | PubTator, text mining | PubMed |
| Perspectives of Quantitative GC-MS, LC-MS, and ICP-MS in the Clinical Medicine Science-The Role of Analytical Chemistry. | J Clin Med | 2024 | 39685736 | PubTator, text mining | PubMed |
| Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA. | Cancers (Basel) | 2024 | 39682151 | PubTator, text mining | PubMed |
| Detection of gene variants associated with recessive limb-girdle muscular weakness and Pompe disease in a global cohort of patients through the application of next-generation sequencing analysis. | Front Genet | 2024 | 39678382 | PubTator, text mining | PubMed |
| Navigating Pompe Disease Assessment: A Comprehensive Scoping Review. | Cureus | 2024 | 39677172 | PubTator, text mining | PubMed |
| No evidence for association between GAA-FGF14 expansion and early onset cerebellar ataxia: a study on 85 undiagnosed patients. | J Neurol | 2024 | 39666057 | PubTator, text mining | PubMed |
| Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA-FGF14-Related Ataxia. | Neurol Genet | 2024 | 39512794 | PubTator, text mining | PubMed |
| Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease. | Front Neurol | 2024 | 39494167 | PubTator, text mining | PubMed |
| Gluconeogenesis and glycogenolysis required in metastatic breast cancer cells. | Front Oncol | 2024 | 39479019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=8